Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar and/or Cisplatin in Malignant Pleural Effusion or Ascites
NCT01327235Phase 2Completed
- Sponsor
- Simcere Pharmaceutical Group
- Start
- Mar 2011
- Primary completion
- Apr 2014
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in malignant pleural effusion (MPE), malignant ascites, sponsored by Simcere Pharmaceutical Group. Started Mar 2011; status: completed.
02
Drugs
endostar
03
Conditions
malignant pleural effusion (MPE)malignant ascites
Beyond the preview
Go deeper on NCT01327235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01327235.